Omzet 2024 * | 2,72 mld. 10,23 mld. 2,56 mld. | Omzet 2025 * | 3,05 mld. 11,47 mld. 2,87 mld. | Marktkapitalisatie | 14,64 mld. 55,02 mld. 13,75 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 439 mln. 1,65 mld. 412 mln. | Nettowinst (verlies) 2025 * | 528 mln. 1,98 mld. 496 mln. | EV/omzet 2024 * | 4,89 x |
Nettoliquiditeiten 2024 * | 1,32 mld. 4,95 mld. 1,24 mld. | Nettoliquiditeiten 2025 * | 2,15 mld. 8,09 mld. 2,02 mld. | EV/omzet 2025 * | 4,09 x |
K/w-verhouding 2024 * |
35,4
x | K/w-verhouding 2025 * |
29,2
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,08% |
Recentste transcriptie over NICE Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 30-04-14 |
Darren Rushworth
PSD | President | 56 | 01-01-17 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 01-10-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 01-08-13 |
David Kostman
CHM | Chairman | 59 | 01-01-01 |
Dan Falk
BRD | Director/Board Member | 79 | 01-01-01 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,93% | 3.004 mld. | |
-1,22% | 79,28 mld. | |
+2,80% | 77,94 mld. | |
-13,87% | 53,9 mld. | |
-19,90% | 50,22 mld. | |
+18,99% | 46,76 mld. | |
+6,91% | 39,49 mld. | |
+35,63% | 31,91 mld. | |
-12,79% | 23,99 mld. |